The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis
| Autor: | Vaz Batista, Marta 1, 2, 17, Pérez-García, José Manuel 2, 3, 17, Garrigós, Laia 3, 4, García-Sáenz, José Ángel 5, Cortez, Patricia 6, Racca, Fabricio 7, Blanch, Salvador 2, 8, Ruiz-Borrego, Manuel 9, Fernández-Ortega, Adela 10, Fernández-Abad, María 11, 12, Iranzo, Vega 13, Gion, María 11, Martrat, Griselda 2, Alcalá-López, Daniel 2, Pérez-Escuredo, Jhudit 2, Sampayo-Cordero, Miguel 2, Llombart-Cussac, Antonio 2, 14, 15, ∗, Braga, Sofia 1, Cortés, Javier 2, 3, 16, 18, ∗∗ |
|---|---|
| Zdroj: | In Med August 2024 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|